Ravulizumab: Difference between revisions
Jump to navigation
Jump to search
(Created page with "__NOTOC__ {{CMG}} {{AE}}") |
Bhavyabella (talk | contribs) No edit summary |
||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{CMG}} {{AE}} | {{CMG}} {{AE}} {{Bhavya}} |
Revision as of 00:26, 2 July 2020
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Bhavya Bellannagari[2]